Skip to content

Publications

Publications

2026

Mergiotti Murabito et al. “Targeting PI3Kγ improves CFTR trafficking.”

JCI Insight. 23 marzo 2026. DOI: 10.1172/jci.insight.198846

2025

“PI3K/Akt in IPF: untangling fibrosis and charting therapies”

Bhatt et al (& Hirsch), Frontiers in Immunology

Review

2024
2023

“It Takes Two to Tango! Protein–Protein Interactions behind cAMP-Mediated CFTR Regulation”

Murabito et al (& Ghigo), International Journal of Molecular Sciences

Review

2022
2021

“Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives”

Sala et al (& Ghigo), European Journal of Medicinal Chemistry

Review

2020

“A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage”

Lupieri et al (& Ghigo, Hirsch), Journal of Cell Science.

Research Article

2018

“Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis”

Campa et al (& Sala, Hirsch), Nature Communications.

Research Article

2017
2012
2011
2005

“Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ”

Vecchione et al (& Hirsch), Journal of Experimental Medicine.

Research Article

2004
2000